Metabolic syndrome in patients with atrial fibrillation in the absence of structural heart disease from a tertiary hospital in China

Chinese Medical Journal

Volumn 122, Issue 22, 2009, Pages 2744-2747

  Tang, Ri Bo ^a   Gao, Ling Yun ^a   Dong, Jian Zeng ^a   Liu, Xiao Hui ^a   Liu, Xing Peng ^a   Wu, Jia Hui ^a   Long, De Yong ^a   Yu, Rong Hui ^a   Du, Xin ^a   Ma, Chang Sheng ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Atrial fibrillation; Catheter ablation; Metabolic syndrome

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHINA; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; ATRIAL FIBRILLATION; CATHETER ABLATION; FEMALE; HEART DISEASES; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE;

EID: 73449106413     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.22.013     Document Type: Article

References (17)

1. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006; 114: 119-125.
2. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359.
3. Umetani K, Kodama Y, Nakamura T, Mende A, Kitta Y, Kawabata K, et al. High prevalence of paroxysmal atrial fibrillation and/or atrial flutter in metabolic syndrome. Circ J 2007; 71: 252-255.
4. Watanabe H, Tanabe N, Watanabe T, Darbar D, Roden DM, Sasaki S, et al. Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation 2008; 117: 1255-1260.
5. Tang RB, Dong JZ, Liu XP, Long DY, Yu RH, Kalifa J, et al. Metabolic syndrome and risk of recurrence of atrial fibrillation after catheter ablation. Circ J 2009; 73: 438-443.
6. Chang SL, Tuan TC, Tai CT, Lin YJ, Lo LW, Hu YF, et al. Comparison of outcome in catheter ablation of atrial fibrillation in patients with versus without the metabolic syndrome. Am J Cardiol 2009; 103: 67-72.
7. Hu R, Ma CS, Nie SP, Lu Q, Kang JP, Du X, et al. Effect of metabolic syndrome on prognosis and clinical characteristics of revascularization in patients with coronary artery disease. Chin Med J 2006; 119: 1871-1876.
8. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: e257-e354.
9. Lu YH, Lu JM, Wang SY, Li CL, Liu LS, Zheng RP, et al. Comparison of the diagnostic criteria of metabolic syndrome by International Diabetes Federation and that by Chinese Medical Association Diabetes Branch. Natl Med J China (Chin) 2006; 86: 386-389.
10. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752.
11. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-3421.
12. Gu DF, Reynolds K, Yang WJ, Chen SF, Wu XG, Duan XF, et al. The prevalence of metabolic syndrome in Chinese adult. Chin J Diabetes (Chin) 2005; 13: 181-186.
13. Movahed MR, Hashemzadeh M, Jamal MM. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol 2005; 105: 315-318.
14. Benjamin EJ, Levy D, Vaziri SM, D?Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994; 271: 840-844.
15. Wang TJ, Parise H, Levy D, D?Agostino RB Sr, Wolf PA, Vasan RS, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 2004; 292: 2471-2477.
16. Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah AS, Habib RH. Obesity and risk of new - onset atrial fibrillation after cardiac surgery. Circulation 2005; 112: 3247-3255.
17. Azevedo A, Bettencourt P, Almeida PB, Santos AC, Abreu-Lima C, Hense HW, et al. Increasing number of components of the metabolic syndrome and cardiac structural and functional abnormalities - cross-sectional study of the general population. BMC Cardiovasc Disord 2007; 7: 17.